Drug Shortage Report for CYANOCOBALAMIN INJECTION USP

Last updated on 2020-02-04 History
Report ID 95366
Drug Identification Number 02463393
Brand name CYANOCOBALAMIN INJECTION USP
Common or Proper name Cyanocobalamin
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) VITAMIN B12
Strength(s) 1000MCG
Dosage form(s) LIQUID
Route of administration INTRAMUSCULAR SUBCUTANEOUS
Packaging size 1 mL
ATC code B03BA
ATC description VITAMIN B12 AND FOLIC ACID
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-10-01
Estimated end date 2020-01-31
Actual end date 2020-02-03
Shortage status Resolved
Updated date 2020-02-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2020-02-04 French Compare
v10 2020-02-04 English Compare
v9 2019-12-27 French Compare
v8 2019-12-27 English Compare
v7 2019-12-10 French Compare
v6 2019-12-10 English Compare
v5 2019-11-11 French Compare
v4 2019-11-11 English Compare
v3 2019-10-03 French Compare
v2 2019-10-03 English Compare
v1 2019-10-03 English Compare

Showing 1 to 11 of 11